Measuring movement disorders in antipsychotic drug trials: the need to define a new standard.
Loonen
Anton J M
AJ
van Praag
Herman M
HM
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000266:history; D018849:Controlled Clinical Trials as Topic; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D023381:Endpoint Determination; D049673:History, 20th Century; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D009460:Neurologic Examination / Q000379:methods* / Q000592:standards; D012016:Reference Values
D014150:Antipsychotic Agents